Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Receivables (2016 - 2025)

Healthstream (HSTM) has disclosed Receivables for 16 consecutive years, with $39.0 million as the latest value for Q4 2025.

  • Quarterly Receivables rose 10.41% to $39.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $39.0 million through Dec 2025, up 10.41% year-over-year, with the annual reading at $39.0 million for FY2025, 10.41% up from the prior year.
  • Receivables for Q4 2025 was $39.0 million at Healthstream, up from $33.7 million in the prior quarter.
  • The five-year high for Receivables was $47.3 million in Q1 2023, with the low at $30.7 million in Q3 2021.
  • Average Receivables over 5 years is $36.8 million, with a median of $35.7 million recorded in 2024.
  • The sharpest move saw Receivables decreased 24.25% in 2021, then grew 22.31% in 2022.
  • Over 5 years, Receivables stood at $34.9 million in 2021, then grew by 22.31% to $42.7 million in 2022, then decreased by 9.98% to $38.4 million in 2023, then fell by 8.13% to $35.3 million in 2024, then increased by 10.41% to $39.0 million in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $39.0 million, $33.7 million, and $31.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.